90 related articles for article (PubMed ID: 2368984)
1. Neuroendocrine differentiation in "poorly differentiated" colon carcinomas.
Staren ED; Gould VE; Jansson DS; Hyser M; Gooch GT; Economou SG
Am Surg; 1990 Jul; 56(7):412-9. PubMed ID: 2368984
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine differentiation and prognosis of extrahepatic biliary tract carcinomas.
Hsu W; Deziel DJ; Gould VE; Warren WH; Gooch GT; Staren ED
Surgery; 1991 Oct; 110(4):604-10; discussion 610-1. PubMed ID: 1718046
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of colon carcinomas applying exocrine and neuroendocrine markers.
Jansson D; Gould VE; Gooch GT; Rittenhouse HG; Shin SS; Manderino GL; Tomita JT; Staren ED
APMIS; 1988 Dec; 96(12):1129-39. PubMed ID: 2463847
[TBL] [Abstract][Full Text] [Related]
4. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine cell differentiation of poorly differentiated colorectal adenocarcinoma correlates with liver metastasis.
Shinji S; Naito Z; Ishiwata T; Tanaka N; Furukawa K; Suzuki H; Seya T; Kan H; Tsuruta H; Matsumoto S; Matsuda A; Teranishi N; Ohaki Y; Tajiri T
Int J Oncol; 2006 Aug; 29(2):357-64. PubMed ID: 16820877
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers.
Pujol JL; Simony J; Laurent JC; Richer G; Mary H; Bousquet J; Godard P; Michel FB
Cancer Res; 1989 May; 49(10):2797-802. PubMed ID: 2540908
[TBL] [Abstract][Full Text] [Related]
7. The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium.
Taraif SH; Deavers MT; Malpica A; Silva EG
Int J Gynecol Pathol; 2009 Mar; 28(2):142-7. PubMed ID: 19188820
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and ultrastructural features of neuroendocrine differentiated carcinomas of the prostate: an immunoelectron microscopic study.
Hirano D; Jike T; Okada Y; Minei S; Sugimoto S; Yamaguchi K; Yoshikawa T; Hachiya T; Yoshida T; Takimoto Y
Ultrastruct Pathol; 2005; 29(5):367-75. PubMed ID: 16257863
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical and morphometric studies on neuroendocrine differentiation of prostate carcinomas].
Bohrer MH; Schmoll J
Verh Dtsch Ges Pathol; 1993; 77():107-10. PubMed ID: 7511265
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms.
Blobel GA; Gould VE; Moll R; Lee I; Huszar M; Geiger B; Franke WW
Lab Invest; 1985 Jan; 52(1):39-51. PubMed ID: 2981372
[TBL] [Abstract][Full Text] [Related]
11. The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon.
Foley EF; Gaffey MJ; Frierson HF
Arch Pathol Lab Med; 1998 Oct; 122(10):912-4. PubMed ID: 9786353
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
[TBL] [Abstract][Full Text] [Related]
14. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience.
Saclarides TJ; Szeluga D; Staren ED
Dis Colon Rectum; 1994 Jul; 37(7):635-42. PubMed ID: 8026228
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.
Papotti M; Macrì L; Finzi G; Capella C; Eusebi V; Bussolati G
Semin Diagn Pathol; 1989 May; 6(2):174-88. PubMed ID: 2503862
[TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
[TBL] [Abstract][Full Text] [Related]
18. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
[TBL] [Abstract][Full Text] [Related]
19. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
20. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
Poincloux L; Durando X; Seitz JF; Thivat E; Bardou VJ; Giovannini MH; Parriaux D; Barriere N; Giovannini M; Delpero JR; Monges G
Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
